Newborn Bloodspot Screening
Cross-source consensus on Newborn Bloodspot Screening from 1 sources and 5 claims.
1 sources · 5 claims
Uses
Benefits
Preparation
Risks & contraindications
Highlighted claims
- The study screen is conducted in parallel with standard newborn screening using the same bloodspot sample. — NewbornsInSA multi-omic newborn screening: protocol for a prospective cohort study
- Screening in the first week of life before symptoms appear enables earlier targeted treatment and reduces morbidity and mortality. — NewbornsInSA multi-omic newborn screening: protocol for a prospective cohort study
- Australian newborn bloodspot screening is universal, free, and screens nearly 300,000 newborns annually. — NewbornsInSA multi-omic newborn screening: protocol for a prospective cohort study
- The current Australian programme screens for about 30 conditions and detects about 1 in 800 babies annually with serious but treatable conditions. — NewbornsInSA multi-omic newborn screening: protocol for a prospective cohort study
- Current newborn bloodspot screening is limited because it detects only a small subset of treatable childhood conditions. — NewbornsInSA multi-omic newborn screening: protocol for a prospective cohort study